NCT03177343View on ClinicalTrials.gov

Pristinamycin in the Treatment of MSSA Bone and Joint Infection

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Methicillin Susceptible Staphylococcus Aureus (MSSA) InfectionBone and Joint Infection
Trial Locations (1)

69004

Hospices Civils de Lyon - Hopital de la Croix Rousse - Centre de reference des infection ostéo-articulaires de Lyon, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03177343 - Pristinamycin in the Treatment of MSSA Bone and Joint Infection | Biotech Hunter | Biotech Hunter